SCHEDULE: 325 Capital Exits Entire Astronics Stake
Schedule 13D Amendment
325 Capital and its affiliates have fully divested their beneficial ownership in Astronics Corp., ceasing to hold any common stock.
Summary
- 325 Capital Master Fund LP, 325 Capital GP, LLC, 325 CAPITAL LLC, Michael Braner, Daniel M. Friedberg, and Anil K. Shrivastava (collectively, the "Reporting Persons") no longer beneficially own any shares of Astronics Corp.
- As of October 15, 2025, the Reporting Persons ceased to beneficially own more than 5% of Astronics Corp.'s outstanding shares.
- The aggregate beneficial ownership of the Reporting Persons is now 0 shares, representing 0% of the 31,619,410 shares outstanding as of October 30, 2025.
- Over the last 60 days, specifically between December 15, 2025, and January 2, 2026, 325 Capital LLC executed multiple open market sales of common stock.
- A total of 816,101 shares were sold during this period, with volume-weighted average sale prices ranging from $50.7984 to $56.2934 per share.
Sentiment
Score: 3
Explanation: The complete divestment by a significant institutional investor typically signals a negative outlook on the company's prospects from that investor's perspective, potentially leading to downward pressure on the stock price.
Negatives
- A significant institutional investor, 325 Capital, has fully divested its stake in Astronics Corp., which could be interpreted as a lack of confidence in the company's future prospects.
- The sale of 816,101 shares over a short period could exert downward pressure on the stock price due to increased supply in the market.
Future Outlook
The filing does not contain any forward-looking statements or guidance from Astronics Corp. or the Reporting Persons regarding the company's future performance.
Industry Context
This filing reflects a specific investment decision by 325 Capital to exit its position in Astronics Corp. It does not provide broader insights into industry trends or competitive landscape, but rather indicates a change in a significant investor's portfolio allocation.
Stakeholder Impact
- Shareholders may react negatively to the news of a significant institutional investor fully divesting its stake, potentially leading to a decrease in share price.
- The divestment could reduce institutional ownership and liquidity for Astronics Corp. shares.
Key Dates
| Date | Description |
|---|---|
| 2025-10-15 | Date Reporting Persons ceased to beneficially own more than 5% of outstanding shares of Astronics Corp. |
| 2025-10-30 | Date for which 31,619,410 shares outstanding were reported in Issuer's 10-Q. |
| 2025-11-06 | Date Issuer's Quarterly Report on Form 10-Q was filed, disclosing shares outstanding. |
| 2025-12-15 | First date of common stock sales by 325 Capital LLC within the last 60 days. |
| 2026-01-02 | Last date of common stock sales by 325 Capital LLC within the last 60 days. |
| 2026-01-15 | Date of filing and signatures for this Schedule 13D Amendment No. 2. |
Recommendation
holdWhile the complete divestment by 325 Capital is a negative signal, this filing alone does not provide sufficient information on Astronics Corp.'s fundamentals or future prospects to warrant a 'sell' recommendation. Investors should 'hold' and await further company-specific news or financial reports to assess the underlying reasons for this divestment and its potential impact on the company's valuation.
Keywords
Astronics Corp, 325 Capital, Schedule 13D/A, Divestment, Share Sale, Institutional Investor, Common Stock, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.